Tech Company Inital Public Offerings
EndoChoice IPO
Headquartered in Alpharetta, EndoChoice is now a public company.
Transaction Overview
Company Name
Announced On
6/5/2015
Transaction Type
IPO
Amount
$96,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
11405 Old Roswell Rd.
Alpharetta, GA 30009
USA
Alpharetta, GA 30009
USA
Phone
Website
Email Address
Overview
EndoChoice, a platform GI company, provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Gilreath
Chief Financial Officer
David Gill
Chief Marketing Officer
Douglas Ladd
Chief Operating Officer
Kevin Rubey
VP - Bus. Development
Will Parks
VP - General Counsel
Brit Young
VP - Human Resources
Kristen Schuller
VP - R & D
Yaniv Kirma
VP - Regulatory Affairs
Nigel Wilkinson
VP - Sales
Gregg Costantino
Browse more venture capital transactions:
Prev: 6/5/2015: Western Oncolytics venture capital transaction
Next: 6/5/2015: Ioxus venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs